مرکز منطقه ای اطلاع رساني علوم و فناوري - 0-72. Rivizor® versus aminoglutethimide (AG) in the second-line endocrine treatment of postmenopausal patients with advanced breast cancer (ABC) following tamoxifen failure

Title of article :

0-72. Rivizor® versus aminoglutethimide (AG) in the second-line endocrine treatment of postmenopausal patients with advanced breast cancer (ABC) following tamoxifen failure

Author/Authors :

Houston S. J.، نويسنده ,

Issue Information :

روزنامه با شماره پیاپی سال 1997

Pages :

From page :

244

To page :

245

Journal title :

The Breast

Serial Year :

1997

Journal title :

The Breast

Record number :

453941

Link To Document :

https://search.isc.ac/dl/search/defaultta.aspx?DTC=10&DC=453941